Enveric Biosciences - Investor Summit Group

Enveric Biosciences

Ticker

ENVB

Website

Sector

Biotech

Tearsheet

Why Invest

"Powerful IP portfolio with 14 Patents filed. Multi-billion dollar opportunities with large patient populations in mind and body. Psybrary contains 1M+ molecules encompassing Gen2 and Gen3, including non hallucinogenics. PsyAI, ENVB's AI arm, allows us to target indications and accelerate pathway to an IND. Experienced Team from Discovery through Phase 3 Clinicals - Strong Financial Position:$20M in cash and NASDAQ traded."